Page 148 - Read Online

Sobenin et al. Vessel Plus 2019;3:14 I http://dx.doi.org/10.20517/2574-1209.2018.63 Page 9 of 10

Copyright
© The Author(s) 2019.

REFERENCES
1. Zabaneh D, Balding DJ. A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 2011;5:e11961.
2. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, et al. A bivariate genome-wide approach to metabolic syndrome:
STAMPEED consortium. Diabetes 2011;60:1329-39.
3. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, et al. Genome-wide screen for metabolic syndrome susceptibility Loci
reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ
Cardiovasc Genet 2012;5:242-9.
4. Avery CL, He Q, North KE. A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic
syndrome phenotype domains. PLoS Genet 2011;7:e1002322.
5. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and
classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
6. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. european group for the study of insulin
resistance (EGIR). Diabet Med 1999;16:442-3.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of
the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in
adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
8. Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C, et al. Definition of metabolic syndrome: report of the National, Heart,
Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
9. Alberti KG, Zimmet P, Shaw J. IDF epidemiology task force consensus group. The metabolic syndrome - a new worldwide definition.
Lancet 2005;366:1059-62.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. Harmonizing the metabolic syndrome: a joint interim statement
of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American
heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity.
Circulation 2009;120:1640-5.
11. Rankinen T, Sarzynski MA, Ghosh S, Bouchard C. Are there genetic paths common to obesity, cardiovascular disease outcomes, and
cardiovascular risk factors? Circ Res 2015;116:909-22.
12. Sazonova M, Budnikov E, Khasanova Z, Sobenin I, Postnov A, et al. Studies of the human aortic intima by a direct quantitative assay of
mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204:184-90.
13. Sobenin IA, Sazonova MA, Postnov AY, Bobryshev YV, Orekhov AN. Mitochondrial mutations are associated with atherosclerotic
lesions in the human aorta. Clin Dev Immunol 2012;2012:832464.
14. Sobenin IA, Sazonova MA, Postnov AY, Bobryshev YV, Orekhov AN. Changes of mitochondria in atherosclerosis: possible determinant
in the pathogenesis of the disease. Atherosclerosis 2013;227:283-8.
15. Sazonova MA, Sinyov VV, Barinova VA, Ryzhkova AI, Zhelankin AV, et al. Mosaicism of mitochondrial genetic variation in
atherosclerotic lesions of the human aorta. Biomed Res Int 2015;2015:825468.
16. Sobenin IA, Sazonova MA, Ivanova MM, Zhelankin AV, Myasoedova VA, et al. Mutation C3256T of mitochondrial genome in white
blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS One 2012;7:e46573.
17. Sobenin IA, Sazonova MA, Postnov AY, Salonen JT, Bobryshev YV, et al. Association of mitochondrial genetic variation with carotid
atherosclerosis. PLoS One 2013;8:e68070.
18. Sazonova MA, Chicheva MM, Zhelankin AV, Sobenin IA, Bobryshev YV, et al. Association of mutations in the mitochondrial genome
with the subclinical carotid atherosclerosis in women. Exp Mol Pathol 2015;99:25-32.
19. Sinyov VV, Sazonova MA, Ryzhkova AI, Galitsyna EV, Melnichenko AA, et al. Potential use of buccal epithelium for genetic diagnosis
of atherosclerosis using mtDNA mutations. Vessel Plus 2017;1:145-50.
20. Sazonova MA, Ryzhkova AI, Sinyov VV, Galitsyna EV, Orekhova VA, et al. New markers of atherosclerosis: a threshold level of
heteroplasmy in mtDNA mutations. Vessel Plus 2017;1:182-91.
21. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A
population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
Circulation 1995;92:1758-64.
22. Sobenin IA, Surnin SA, Karagodin VP, Miasoedova VA, Kirichenko TV, et al. Variability of intima-media thickness of the common
carotid arteries in Moscow city population without clinical symptoms of atherosclerosis. Ter Arkh 2011;83:58-62.
23. Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation in mitochondrial complex I genes: mutation or
polymorphism? J Med Genet 2006;43:175-9.
24. Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 2007;83:84-92.
25. Springer MS, Douzery E. Secondary structure and patterns of evolution among mammalian mitochondrial 12S rRNA molecules. J Mol
Evol 1996;43:357-73.
26. Shen SS, Liu C, Xu ZY, Hu YH, Gao GF, et al. Heteroplasmy levels of mtDNA1555A>G mutation is positively associated with diverse
phenotypes and mutation transmission in a Chinese family. Biochem Biophys Res Commun 2012;420:907-12.
27. Ealy M, Lynch KA, Meyer NC, Smith RJ. The prevalence of mitochondrial mutations associated with aminoglycoside-induced
sensorineural hearing loss in an NICU population. Laryngoscope 2011;121:1184-6.